Clinical Trial Update: An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis [Phase 2]

View source ↗

Summary

Phase 2 open-label clinical trial evaluating immunomodulatory medications for Relapsing Polychondritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Polychondritis

Snippet

Sponsor: University of Pennsylvania | Conditions: Relapsing Polychondritis | Phase 2 | Status: RECRUITING